Raia Drogasil

What Raia Drogasil does

Raia Drogasil is Brazil's largest pharmacy chain, operating two flagship retail brands — Raia and Drogasil — across Brazil under parent company RD Saúde following the 2011 merger of the two chains. The company provides prescription medications, over-the-counter products, health and wellness goods, private-label exclusive brands, and a growing portfolio of digital health services including online commerce, telemedicine, and clinic management software. Its digital channel scaled from approximately 1% of revenue in 2018 to nearly one-third by 2024, reflecting an aggressive multi-year omnichannel transformation.

The technology stack combines an in-house digital commerce platform with acquired healthtech assets. Through wholly-owned subsidiary Amplimed, Raia Drogasil operates a SaaS clinic management and telemedicine platform serving over 20,000 health professionals connected to multiple healthcare entities. Healthbit (majority-owned) provides health data analytics for disease prevention; additional subsidiaries include a pharmacy marketplace and broader health app distribution, plus corporate venture arm RD Saúde Ventures for ongoing healthtech investment. Underlying administrative expense intensity rose from 13% to 30% of revenue (2018-2024) to fund this buildout.

Raia Drogasil generates revenue primarily through transaction-based physical pharmacy retail (approximately two-thirds of revenue), digital commerce and e-commerce including telemedicine (approaching one-third by 2024), and B2B subscription SaaS through Amplimed serving healthcare professionals. The go-to-market is hybrid: omnichannel consumer retail across Brazil with a foundational physical store base, paired with B2B SaaS distribution to clinics and physicians. Customer segments span long-tail consumer pharmacy patients and healthcare providers using Amplimed; founding family governance is credited with enabling long-term capital deployment through downturns (notably the 2015 crisis) and through the multi-year margin pressure of digital buildout.

Name

Raia Drogasil

Legal name

Raia Drogasil S.A.

Website

https://rd.com.br

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Raia Drogasil, operating under parent company RD Saúde, is Brazil's largest pharmacy chain offering prescription drugs, OTC products, digital commerce, telemedicine, and clinic management SaaS to Brazilian consumers and 20,000+ healthcare professionals.

Ownership category

akta.pro rank

Product category

Retail Pharmacy

NAICS

Pharmacies and Drug Retailers (45611)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Pharmacy-Led Health & Wellness Discount Retail (CRAEAHAD)

akta.pro secondary industries

Health, Wellness & Pharmacy Marketplaces (CRAFABAF), Health & Pharmacy Omnichannel (CRAFAEAK), Pharmacy & Health Essentials Delivery (CRAFAFAI)

Keywords

• Retail pharmacy operations
• Drugstore chain
• Pharmaceutical retail
• Telemedicine services
• Health data analytics

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmacy Retail Sales: Physical pharmacy retail operations through Raia and Drogasil pharmacy chains, representing approximately two-thirds of total revenue as digital sales approach one-third
2. Digital Commerce: Online sales platform that grew from 1% of revenue in 2018 to nearly one-third of total business by 2024, including e-commerce and telemedicine services
3. Healthcare SaaS Services: Subscription-based SaaS software for clinic management and telemedicine serving over 20,000 health professionals through the Amplimed acquisition

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Raia Drogasil S.A. operates Brazil's largest pharmacy chain network under the Raia and Drogasil retail brands, selling prescription medications, OTC pharmaceuticals, and health and wellness products through physical stores and a digital commerce platform. The company has built an integrated health ecosystem that extends into digital health services, including an online telemedicine platform, the Amplimed SaaS for clinic management and telemedicine serving over 20,000 health professionals, and Healthbit's health data analytics capabilities. The retail pharmacy business represents approximately two-thirds of total revenue, with digital sales approaching one-third of revenue by 2024.

Product overview

Raia Drogasil operates under the parent company RD Saúde as a major Brazilian pharmacy retailer with two flagship pharmacy chains (Raia and Drogasil), complemented by digital health services including an online telemedicine platform. The company has expanded through strategic acquisitions including Amplimed (clinic management SaaS and telemedicine serving 20,000+ health professionals) and Healthbit (health data analytics for disease prevention). The portfolio also includes RD Saúde Ventures for startup investments, exclusive private-label brands, and Impulso for media/partnership initiatives. The company is pursuing an aggressive digital transformation strategy, with digital sales now accounting for nearly one-third of total business.

Differentiator

Problem solved

Functional benefit

Brands

• RD Saúde Ventures: Venture arm focused on health technology investments and innovation
• Impulso

Products and services

• Raia Farmácias Retail pharmacy chain under RD Saúde offering prescription medications, OTC products, and health services to Brazilian consumers through physical stores.
• Drogasil Farmácias Retail pharmacy chain under RD Saúde providing prescription medications, OTC products, and health services to Brazilian consumers through physical stores.
• Online Telemedicine Platform (Telemedicina Online) Online telemedicine platform enabling remote healthcare consultations as part of the Raia Drogasil (RD Saúde) health services offering.
• Amplimed Clinic Management and Telemedicine SaaS SaaS software for clinic management and telemedicine that serves more than 20,000 health professionals and connects with multiple healthcare entities, operated as part of RD Saúde's health ecosystem.
• Healthbit Health Data Analytics Health data analytics offering focused on disease prevention through health data analysis, operated within the RD Saúde health ecosystem after Raia Drogasil acquired a majority stake in Healthbit.

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and supporting.

• AmplimedcoreStrategic or Co-development Partner · 13 January 2022Acquisition of healthtech startup Amplimed as part of Raia Drogasil's strategy to strengthen its health ecosystem. The deal includes Amplimed's SaaS software for clinic management and telemedicine, which serves over 20,000 health professionals and connects with multiple healthcare entities. Amplimed is described as a leader in healthcare management software.
• HealthbitcoreStrategic or Co-development Partner · 3 November 2021Acquisition of majority stake in Healthbit, a health data startup, to enhance disease prevention efforts. Healthbit provides health data analytics capabilities that complement Raia Drogasil's health ecosystem strategy.
• RD Saúde VenturescoreStrategic or Co-development PartnerCorporate venture arm of Raia Drogasil focused on investing in and developing new health-related businesses and technologies. Part of the company's strategy to build a comprehensive health ecosystem.
• Commercial Partners (Parceiros Comerciais)supportingChannel Partner/ Reseller/ DistributorCommercial partnership program under RD Saúde targeting business partners interested in collaborating with the company's retail and health ecosystem.
• Impulso (Impulso Midia)supportingChannel Partner/ Reseller/ DistributorMarketing and media partnership through Impulso platform, supporting commercial partners and business development within the RD Saúde ecosystem.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Amazon Pharmacy: Online-first pharmacy retail entrant gaining traction across multiple geographies. Comparable as a digital-pharmacy competitor that pressures incumbents' digital sales mix and last-mile economics.

Broad incumbents

• CVS Health: US pharmacy retail + health services + PBM conglomerate. Comparable on the integrated retail-pharmacy-plus-clinic-plus-health-services model RD is building, though far larger and more diversified.
• Celesio / McKesson Europe: European pharmaceutical wholesaler and pharmacy operator (Lloyds Pharmacy). Comparable as a combined pharma distribution + retail pharmacy + services business operating at continental scale.
• Walgreens Boots Alliance: Global pharmacy-led health and beauty retailer with physical stores and growing digital health services. Highly comparable on the pharmacy + health ecosystem positioning RD is pursuing in Brazil.

Direct peers

• Pague Menos: Brazilian pharmacy chain and one of RD's principal domestic competitors. Comparable in product mix (Rx, OTC, health & wellness) and in operating an omnichannel model across physical stores and digital channels.
• Shoppers Drug Mart (Loblaw Companies): Canada's largest pharmacy chain, integrated with food retail via its parent Loblaw. Comparable as a pharmacy-led retailer with loyalty program, in-store clinics, and digital health services.
• Panvel: Brazilian pharmacy retailer with both physical stores and a strong e-commerce/digital pharmacy platform. Closely comparable on omnichannel retail pharmacy, beauty/wellness assortment, and digital sales growth.
• Phoenix Group: European pharmacy retail and wholesale group operating national pharmacy chains. Comparable on scale-driven pharmacy retail leadership and on building pharmacy-plus-services ecosystems.
• DPSP (Drogarias Pacheco / São Paulo): Major Brazilian drugstore chain resulting from the merger of Drogarias Pacheco and Drogaria São Paulo. Directly competes with RD in pharmacy retail across multiple Brazilian states.

Others

• Drogaria Raia (pre-merger) / Drogasil (pre-merger): Pre-merger predecessor brands (Raia and Drogasil) that combined to form Raia Drogasil in 2011. Included as historical reference for RD's chain identity and footprint evolution rather than as a current competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/raia-drogasil
• Instagraminstagram.com/rdsaudeoficial

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A5 records

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Raia Drogasil